{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:34:51Z","timestamp":1787164491589,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cerebrospinal fluid (CSF) analyses are recommended in patients with meningitis and\/or encephalitis, but evidence regarding its diagnostic yield is low. We aimed to determine predictors of infectious pathogens in the CSF of adult patients presenting with meningitis, and\/or encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Consecutive patients with meningitis and\/or encephalitis form 2011\u201317 at a Swiss academic medical\u00a0care center were included in this cross-sectional study. Clinical, neuroradiologic, and laboratory data were collected as exposure variables. Infectious meningitis and\/or encephalitis were defined as the composite outcome.<\/jats:p>\n                    <jats:p>\n                      For diagnosis of bacterial meningitis the recommendations of the European Society of Clinical Microbiology and Infectious Diseases were followed. Viral meningitis was diagnosed by detection of viral ribonucleic or deoxyribonucleic acid in the CSF. Infectious encephalitis was defined according to the International Encephalitis Consortium (IEC). Meningoencephalitis was diagnosed if the criteria for meningitis and encephalitis were fulfilled. Multinomial logistic regression was performed to identify predictors of the composite outcome. To quantify discriminative power, the c statistic analogous the area under the receiver-operating curve (AUROC) was calculated. An AUROC between 0.7\u20130.8 was defined as \u201cgood\u201d, 08\u20130.9 as \u201cexcellent\u201d, and\u2009&gt;\u20090.9 as \u201coutstanding\u201d. Calibration was defined as \u201cgood\u201d if the goodness of fit tests revealed insignificant\n                      <jats:italic>p<\/jats:italic>\n                      -values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 372 patients, infections were diagnosed in 42.7% presenting as meningitis\u00a0(51%), encephalitis\u00a0(32%), and meningoencephalitis\u00a0(17%). Most frequent infectious pathogens were\n                      <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                      ,\n                      <jats:italic>Varicella zoster, and Herpes simplex 1&amp;2.<\/jats:italic>\n                      While in multivariable analysis lactate concentrations and decreased glucose ratios were the only independent predictors of bacterial infection (AUROCs 0.780, 0.870, and 0.834 respectively), increased CSF mononuclear cells were the only predictors of viral infections (AUROC 0.669). All predictors revealed good calibration.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Prior to microbiologic workup, CSF data may guide clinicians when infection is suspected while other laboratory and neuroradiologic characteristics seem less useful. While increased CSF lactate and decreased glucose ratio are\n                      <jats:strike>is<\/jats:strike>\n                      the most reliable predictors of bacterial infections in patients with meningitis and\/or encephalitis, only mononuclear cell counts predicted viral infections.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov identifier\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03856528\">NCT03856528<\/jats:ext-link>\n                      . Registered on February 26th 2019.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05022-6","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T12:02:48Z","timestamp":1587643368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Predictors of infectious meningitis or encephalitis: the yield of cerebrospinal fluid in a cross-sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Tolga","family":"Dittrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Egli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"R\u00fcegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Marco","family":"De Marchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tschudin-Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"Suppl 3","key":"5022_CR1","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.cmi.2016.01.007","volume":"22","author":"D van de Beek","year":"2016","unstructured":"van de Beek D, Cabellos C, Dzupova O, Esposito S, Klein M, Kloek AT, Leib SL, Mourvillier B, Ostergaard C, Pagliano P, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22(Suppl 3):S37\u201362.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"5022_CR2","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, Tunkel AR, Bloch KC, Lauring AS, Sejvar J, Bitnun A, Stahl JP, Mailles A, Drebot M, Rupprecht CE, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114\u201328.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"5022_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12028-017-0455-y","volume":"27","author":"DF Gaieski","year":"2017","unstructured":"Gaieski DF, O'Brien NF, Hernandez R. Emergency neurologic life support: meningitis and encephalitis. Neurocrit Care. 2017;27(Suppl 1):124\u201333.","journal-title":"Neurocrit Care"},{"issue":"9","key":"5022_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267\u201384.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5022_CR5","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cmi.2018.12.022","volume":"25","author":"MC Zanella","year":"2019","unstructured":"Zanella MC, Lenggenhager L, Schrenzel J, Cordey S, Kaiser L. High-throughput sequencing for the aetiologic identification of viral encephalitis, meningoencephalitis and meningitis. A narrative review and clinical appraisal. Clin Microbiol Infect. 2019;25(4):422\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"1\u20132","key":"5022_CR6","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1093\/milmed\/usx025","volume":"183","author":"D Chang","year":"2018","unstructured":"Chang D, Okulicz JF, Nielsen LE, White BK. A tertiary care Center's experience with novel molecular meningitis\/encephalitis diagnostics and implementation with antimicrobial stewardship. Mil Med. 2018;183(1\u20132):e24\u20137.","journal-title":"Mil Med"},{"issue":"7","key":"5022_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/23744235.2018.1441539","volume":"50","author":"K Buch","year":"2018","unstructured":"Buch K, Bodilsen J, Knudsen A, Larsen L, Helweg-Larsen J, Storgaard M, Brandt C, Wiese L, Ostergaard C, Nielsen H, et al. Cerebrospinal fluid lactate as a marker to differentiate between community-acquired acute bacterial meningitis and aseptic meningitis\/encephalitis in adults: a Danish prospective observational cohort study. Infect Dis (Lond). 2018;50(7):514\u201321.","journal-title":"Infect Dis (Lond)"},{"issue":"10","key":"5022_CR8","doi-asserted-by":"publisher","first-page":"1102 e1101","DOI":"10.1016\/j.cmi.2018.01.016","volume":"24","author":"J Bodilsen","year":"2018","unstructured":"Bodilsen J, Storgaard M, Larsen L, Wiese L, Helweg-Larsen J, Lebech AM, Brandt C, Ostergaard C, Nielsen H. group Ds: Infectious meningitis and encephalitis in adults in Denmark: a prospective nationwide observational cohort study (DASGIB). Clin Microbiol Infect. 2018;24(10):1102 e1101\u20135.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"5022_CR9","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1128\/JCM.00730-16","volume":"54","author":"AL Leber","year":"2016","unstructured":"Leber AL, Everhart K, Balada-Llasat JM, Cullison J, Daly J, Holt S, Lephart P, Salimnia H, Schreckenberger PC, DesJarlais S, et al. Multicenter evaluation of BioFire FilmArray meningitis\/encephalitis panel for detection of Bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251\u201361.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"5022_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0361-9230(03)00092-3","volume":"61","author":"P Zwerenz","year":"2003","unstructured":"Kleine TO, Zwerenz P, Zofel P, Shiratori K. New and old diagnostic markers of meningitis in cerebrospinal fluid (CSF). Brain Res Bull. 2003;61(3):287\u201397.","journal-title":"Brain Res Bull"},{"issue":"6","key":"5022_CR11","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/00003246-200006000-00024","volume":"28","author":"S Schwarz","year":"2000","unstructured":"Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med. 2000;28(6):1828\u201332.","journal-title":"Crit Care Med"},{"issue":"3","key":"5022_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/BF01724802","volume":"16","author":"B Genton","year":"1990","unstructured":"Genton B, Berger JP. Cerebrospinal fluid lactate in 78 cases of adult meningitis. Intensive Care Med. 1990;16(3):196\u2013200.","journal-title":"Intensive Care Med"},{"issue":"4","key":"5022_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/JCM.11.4.324-327.1980","volume":"11","author":"R Lannigan","year":"1980","unstructured":"Lannigan R, MacDonald MA, Marrie TJ, Haldane EV. Evaluation of cerebrospinal fluid lactic acid levels as an aid in differential diagnosis of bacterial and viral meningitis in adults. J Clin Microbiol. 1980;11(4):324\u20137.","journal-title":"J Clin Microbiol"},{"issue":"9596","key":"5022_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"key":"5022_CR15","doi-asserted-by":"crossref","unstructured":"Dittrich T, Marsch S, Ruegg S, De Marchis GM, Tschudin-Sutter S, Sutter R. Delirium in Meningitis and Encephalitis: Emergence and Prediction in a 6-Year Cohort. J Intensive Care Med. 2020; epub ahead of print.","DOI":"10.1177\/0885066620913004"},{"issue":"5","key":"5022_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"10","key":"5022_CR17","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH. A definition and classification of status epilepticus--report of the ILAE task force on classification of status Epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"},{"issue":"22","key":"5022_CR18","first-page":"464","volume":"17","author":"S von Arxa","year":"2017","unstructured":"von Arxa S, Leibb SL, Sturzenegger M, Sendi P. Infektionen des zentralen Nervensystems - Teil 1: Meningitis bei Erwachsenen. Schweiz Med Forum. 2017;17(22):464\u201370.","journal-title":"Schweiz Med Forum"},{"issue":"42","key":"5022_CR19","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.4414\/saez.2005.11526","volume":"86","author":"J Evison","year":"2005","unstructured":"Evison J, Aebi C, Francioli P, P\u00e9ter O, Bassetti S, Gervaixe A, Zimmerli S, Weber R. Abkl\u00e4rung und Therapie der Lyme-Borreliose bei Erwachsenen und Kindern. Schweizerische \u00c4rztezeitung. 2005;86(42):2375\u201384.","journal-title":"Schweizerische \u00c4rztezeitung"},{"issue":"23","key":"5022_CR20","first-page":"492","volume":"17","author":"S von Arxa","year":"2017","unstructured":"von Arxa S, Leibb SL, Sturzenegger M, Sendi P. Infektionen des zentralen Nervensystems - Teil 2: Enzephalitis beim Erwachsenen. Schweiz Med Forum. 2017;17(23):492\u20138.","journal-title":"Schweiz Med Forum"},{"issue":"1","key":"5022_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc B. 1996;58(1):267\u201388.","journal-title":"J R Stat Soc B"},{"key":"5022_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/0471722146","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"2000","unstructured":"Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000. p. 160\u20134.","edition":"2"},{"issue":"3","key":"5022_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/cid\/cix319","volume":"65","author":"R Hasbun","year":"2017","unstructured":"Hasbun R, Rosenthal N, Balada-Llasat JM, Chung J, Duff S, Bozzette S, Zimmer L, Ginocchio CC. Epidemiology of meningitis and encephalitis in the United States, 2011-2014. Clin Infect Dis. 2017;65(3):359\u201363.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5022_CR24","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0736-4679(01)00407-3","volume":"21","author":"JR Miner","year":"2001","unstructured":"Miner JR, Heegaard W, Mapes A, Biros M. Presentation, time to antibiotics, and mortality of patients with bacterial meningitis at an urban county medical center. J Emerg Med. 2001;21(4):387\u201392.","journal-title":"J Emerg Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05022-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05022-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T11:55:36Z","timestamp":1722772536000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05022-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5022"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05022-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"15 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"As the retrospective data collection did not interfere with routine clinical practice and data were safely encoded, the local ethics committee (Ethikkommission Norwest- und Zentralschweiz; No. 2016\u201301244) approved the study in compliance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments, and patients\u2019 consent was waived. The data were anonymized before their use. As all researchers involved in the data collection and analyses were medical employees of the hospital, no additional administrative permissions and\/or licenses were acquired by our team to access the data used in our research and no further permission from the hospital was required to access the medical records of patients.We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None of the authors report conflicts of interests relevant to this study.Tolga Dittrich received a personal grant from the Scientific Society Basel.Stephan Marsch reports no disclosures.Adrian Egli reports no disclosures.Stephan R\u00fcegg received unconditional research grants from UCB and CSL Behring. He received honoraria from serving on the scientific advisory boards of Desitin, Eisai, GlaxoSmithKline, Pfizer and UCB, travel grants from Desitin, speaker fees from UCB and Novartis, compensations from serving as a consultant for Novartis, Sandoz and UCB. He is co-PI of the Swiss National Found Grant #320030_169379 \/ 1. He serves as president on the board of the Swiss League against Epilepsy and is on the editorial board of EPILETOLOGIE and the SWISS EEG BULLETIN. He does not hold any stocks of any pharmaceutical companies or manufacturers of medical devices.Gian Marco De Marchis was or is supported by the Swiss National Science Foundation; Science Funds [Wissenschaftsfonds] of the University Hospital Basel and University of Basel; Bangerter-Rhyner-Stiftung; Swisslife Jubil\u00e4umsstiftung for Medical Research; Swiss Neurological Society; Fondazione Dr. Ettore Balli; De Quervain research grant; Thermo Fisher GmbH. He received travel and advisory board honoraria by Bayer and speaker honoraria by Medtronic and BMS\/Pfizer.Sarah Tschudin-Sutter is a member of the Astellas and MSD Advisory Boards for <i>C. difficile<\/i>, of the Pfizer Antiinfectives Advisory Board for and reports grants from the Swiss National Science Foundation NRP72 (407240_167060), the Bangerter-Rhyner Stiftung, the Fonds zur F\u00f6rderung von Lehre und Forschung der Freiwilligen Akademischen Gesellschaft Basel, and the Jubil\u00e4umsstiftung from Swiss Life.Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Novartis, Roche and Johnson & Johnson.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}